## **Core Concept**
Acute asthma management involves relieving bronchospasm and improving oxygenation. The primary treatment includes bronchodilators, corticosteroids, and sometimes, adjunct therapies. The question tests knowledge of acute asthma pharmacotherapy.

## **Why the Correct Answer is Right**
The correct answer, , is not used in the acute management of asthma. This is because its primary role is in the long-term control and prevention of asthma symptoms, not in acute relief.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is a short-acting beta-2 agonist (SABA) like salbutamol, which is a first-line treatment for acute asthma exacerbations, providing quick relief from bronchospasm.
* **Option B:** is an anticholinergic agent that can be used in acute asthma for additive benefit with beta-2 agonists, especially in severe cases.
* **Option C:** is a corticosteroid, which is crucial in acute asthma for reducing inflammation.

## **Clinical Pearl / High-Yield Fact**
In acute asthma, and are often used together for synergistic effects. Remember that (corticosteroids) are essential for reducing inflammation. A key point is that long-term control medications like are not used for acute relief.

## **Correct Answer:** .